ACTIVE_NOT_RECRUITING

Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors

Talk to us

Conditions

Breast CancerBreast Cancer FemaleBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIMild DepressionModerate DepressionBlack African Americans

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to develop and test an intervention designed to improve mood and reduce symptoms of depression.

Official Title

Community Engagement in the Development of an Abbreviated Mindfulness-Based Cognitive Therapy Intervention for Depression in Older African American/Black Breast Cancer Survivors (Community Minds)

Quick Facts

Study Start:2025-03-21
Study Completion:2026-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06336538

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥65 years old
  2. * fluency in English
  3. * female
  4. * African American/Black
  5. * diagnosis of Stage I, II or III breast cancer
  6. * at least 3 months past active treatment for cancer (chemotherapy, surgery and/or radiation therapy) with no additional treatment scheduled except endocrine therapy
  7. * mild to moderate symptoms of depression (Patient Health Questionnaire-9(26) scores 4-14)
  8. * willing to be audio and video-recorded
  9. * willing to provide written informed consent.
  1. * moderately severe or severe depression (PHQ-9 scores ≥15)
  2. * comorbid psychiatric illness or other psychological disorders that would interfere with the ability to participate in or receive benefit from MBCT-Brief, including generalized social anxiety disorder, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, drug abuse or dependence, bipolar disorder, borderline personality disorder, and active suicidal ideation.
  3. * changes in antidepressant medication within 6 weeks of intake
  4. * prior history of engaging in formal MBIs including Mindfulness-Based Stress Reduction, MBCT, Acceptance and Commitment Therapy, Dialectical Behavior Therapy
  5. * current daily meditation practice

Contacts and Locations

Principal Investigator

Jacob Hill, ND
PRINCIPAL_INVESTIGATOR
Cleveland Clinic Department of Wellness and Preventive Medicine, Cleveland Clinic, Case Comprehensive Cancer Center

Study Locations (Sites)

Cleveland Clinic Department of Wellness and Preventive Medicine
Cleveland, Ohio, 44106
United States

Collaborators and Investigators

Sponsor: Case Comprehensive Cancer Center

  • Jacob Hill, ND, PRINCIPAL_INVESTIGATOR, Cleveland Clinic Department of Wellness and Preventive Medicine, Cleveland Clinic, Case Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-21
Study Completion Date2026-01-31

Study Record Updates

Study Start Date2025-03-21
Study Completion Date2026-01-31

Terms related to this study

Keywords Provided by Researchers

  • Black African Americans

Additional Relevant MeSH Terms

  • Breast Cancer
  • Breast Cancer Female
  • Breast Cancer Stage I
  • Breast Cancer Stage II
  • Breast Cancer Stage III
  • Mild Depression
  • Moderate Depression